Therefore, in the present study, the role and applications of Gal-3 as a diagnostic, prognostic, and risk stratifying biomarker in heart disease and cancer, as well as therapeutic approach, were investigated with special emphasis to prostate cancer (PCa). Here, LGALS3 is linked to prostate carcinoma.